Audio episod ini mungkin rosak.
How to fix it?
MENGENAI EPISOD INI
SLAS Discovery 25.10 December 2020
Rob Howes discusses the paper "High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2" with authors Meredith Gardner (Scripps Research) and Michael Farzan (Scripps Research).
This research is part of the December Special Issue, Drug Discovery Targeting COVID-19 with Associate Editor Tim Spicer.
Bahasa Inggeris
Amerika Syarikat
CARI EPISOD LEPAS
Cari episod lepas bagi SLAS Discovery Author Insights.
EPISOD LAIN DALAM PODCAST INI
Volume 26 Issue 7, August 2021Podcast Editor Rob Howes chats with Jayme L. Dahlin, MD, Ph.D. (National Center for Advancing Translational Sciences (NCATS)), Guest Editor of the Special Collection: Approaches for Prioritizing High-Quality Chemical Matter in Chemical Probe and Drug Discovery.This ...
Volume 26 Issue 4, April 2021Podcast Editor Rob Howes discusses the SLAS Discovery Special Issue on Advances in Protein Degradation with guest editors Paola Castaldi and Stewart Fisher. Targeted protein degradation has generated interest within the drug discovery arena due to the inhibition of o ...
Volume 25 Issue 2, February 2021Podcast Editor Rob Howes chats with Marie-Claire Peakman, Ph.D. (Executive Director, Discovery Sciences, Pfizer), author of the featured paper "Selecting Approaches for Hit Identification and Increasing Options by Building the Efficient Discovery of Actionabl ...
Podcast Editor Rob Howes chats with Geoffrey A. Holdgate, Ph.D. (AstraZeneca) and Christian Bergsdorf, Ph.D. (Novartis), Guest Editors of the Special Collection: Applications of Biophysics in Early Drug Discovery. This special collection explores the use of biophysical methods in the identificat ...
Penafian: Podcast dan karya seni yang dibenamkan pada halaman ini adalah daripada Rob Howes, Ph.D., yang merupakan hak milik pemiliknya dan tidak bergabung dengan atau disokong oleh Listen Notes, Inc.
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.